Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $3.8 million.

  • Phibro Animal Health's Deferred Taxes rose 14958.66% to $3.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $13.8 million, marking a year-over-year increase of 17573.65%. This contributed to the annual value of -$4.9 million for FY2025, which is 5948.35% up from last year.
  • As of Q4 2025, Phibro Animal Health's Deferred Taxes stood at $3.8 million, which was up 14958.66% from $2.2 million recorded in Q3 2025.
  • Phibro Animal Health's Deferred Taxes' 5-year high stood at $8.4 million during Q2 2025, with a 5-year trough of -$7.7 million in Q4 2024.
  • Its 5-year average for Deferred Taxes is -$826900.0, with a median of -$403000.0 in 2021.
  • Per our database at Business Quant, Phibro Animal Health's Deferred Taxes crashed by 2060000.0% in 2023 and then skyrocketed by 25970.21% in 2025.
  • Phibro Animal Health's Deferred Taxes (Quarter) stood at -$506000.0 in 2021, then skyrocketed by 78.66% to -$108000.0 in 2022, then plummeted by 3432.41% to -$3.8 million in 2023, then plummeted by 102.88% to -$7.7 million in 2024, then surged by 149.59% to $3.8 million in 2025.
  • Its Deferred Taxes was $3.8 million in Q4 2025, compared to $2.2 million in Q3 2025 and $8.4 million in Q2 2025.